Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Sleep Initiation and Maintenance Disorders 2Delirium 1Breast Neoplasms 1

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Delirium × suvorexant × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡